ask="4.70"
ask_size="300"
average_daily_volume="178070"
bid="N/A"
bid_size="N/A"
book_value="1.02"
change="-0.15"
change_from_200_day_moving_average="-1.08"
change_from_50_day_moving_average="-0.38"
change_from_52_week_high="-6.26"
change_From_52_week_low="0.10"
change_in_percent="-3.53%"
close="4.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.76"
ebitda="-21.91M"
eps_estimate_current_year="-0.78"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.76"
ex_dividend_date="N/A"
float_shares="30151000"
high="4.30"
high_52_weeks="10.36"
last_trade_date="3/6/2017"
last_trade_price="4.10"
last_trade_size="8025"
last_trade_time="4:00pm"
low="4.10"
low_52_weeks="4.00"
market_capitalization="131.34M"
moving_average_200_day="5.18"
moving_average_50_day="4.48"
name="INVIVO THERAPEUTICS"
notes="N/A"
one_year_target_price="19.42"
open="4.25"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-20.85%"
percent_change_from_50_day_moving_average="-8.49%"
percent_change_from_52_week_high="-60.42%"
percent_change_from_52_week_low="+2.50%"
previous_close="4.25"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.15"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="32033000"
short_ratio="20.18"
stock_exchange="NGM"
symbol="NVIV"
volume="221360"
weeks_range_52="4.00 - 10.36"
